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Jump-starting tumor-speciﬁc T cells
 
Vaccination with tumor antigens causes tumor regression in 
some melanoma patients despite negligible expansion of 
vaccine-specific T cells. Vaccination may instead result in the 
expansion of T cells specific for tumor antigens not contained 
in the vaccine, thus facilitating tumor regression, according to 
two articles from Pierre Coulie and colleagues on pages 241 
and 249.
Tumor-specific T cells can be detected in the blood and the 
tumors of many melanoma patients, and yet these cells are 
unable to kill the tumor. What causes the impotence of these T 
cells is a mystery. Equally mysterious is why vaccination against 
tumor-specific antigens sometimes causes regression without 
expanding large numbers of vaccine-specific killer T cells.
Pierre Coulie’s group studied the specificity of antitumor T cell 
responses in patients vaccinated with a tumor antigen called 
MAGE-3. In one patient whose tumors regressed after vaccination, 
the authors found that T cells specific for nonvaccine tumor 
antigens became detectable or expanded from their prevaccine 
frequencies. Vaccine-specific T cells became detectable but 
remained at low frequency. Thus, reinvigoration of existing tumor-
specific T cells and activation of new T cells after vaccination does 
not require large numbers of vaccine-specific T cells.
Although the mechanism underlying this phenomenon 
Tumor-specific T cells (red) infiltrate a tumor after vaccination.
 
 
 
Rethinking EAE pathogenesis
 
Th1 cells have long been thought to mediate 
the pathogenesis of experimental 
autoimmune encephalitis (EAE), a mouse 
model for multiple sclerosis. But Langrish et 
al. now identify a new subset of T cells as the 
driving force behind brain inflammation in 
EAE (page 233).
Previous thinking on EAE culprits has 
focused on Th1 CD4
 
 
 
 T cells and their 
distinctive product IFN-
 
 
 
, both of which are 
found at EAE inflammation sites. But the 
details were confused by the biology of p40—a subunit shared by both IL-12 
(an inducer of Th1 cells) and IL-23. This group showed recently that EAE is 
suppressed after p40 inactivation because of the loss of IL-23 not IL-12.
The authors now explain the pathogenic effect of IL-23 by showing that this 
cytokine induces a newly recognized subset of CD4
 
 
 
 T cells, which produces large 
amounts of IL-17 and IL-6 but very little IFN-
 
 
 
. These T cells and IFN-
 
 
 
–producing 
Th1 cells both invaded the CNS during EAE in wild-type mice, but only IFN-
 
 
 
–
producing Th1 cells were found in the CNS in mice lacking IL-23. Furthermore, 
T cells cultured in vitro with IL-23, but not those cultured with IL-12, could 
transfer the disease to naive mice.
How these cells induce disease is not completely understood. IL-17 appears 
to be a key player, as blocking IL-17 in wild-type mice partially reversed disease. 
IL-17 is known to drive the production of inflammatory cytokines from memory 
T cells, and IL-23 induces proliferation of these cells—both of which may amplify 
inflammation. Whatever the mechanism, this study appears to exonerate 
traditional Th1 cells as the main players in the pathogenesis of EAE.
CD4+ T cells cultured in vitro 
with IL-23 ( ), but not IL-12 
( ) induce EAE pathogenesis.
 
remains unknown, Coulie thinks that the few T cells 
stimulated by the vaccine may change the local environment 
of the tumor such that existing T cells can be reactivated and 
new T cells can be recruited.
 
study that IL-12 also promotes DNA
repair, but it was unclear how (or if)
these functions of IL-12 related to one
another.
The group now shows that the
prevention of UV-induced immuno-
suppression relies on DNA repair. Mice
that lacked the DNA repair machinery
became immunocompromised after UV
exposure even after they were given
IL-12. In wild-type mice, IL-12 pro-
tected against immunosuppression.
Thus, IL-12 interference with im-
munosuppression appears to be de-
pendent on its induction of DNA
repair. The authors suggest that DNA
damage may change the costimula-
tory molecules expressed on LCs,
thus altering their stimulatory pro-
file away from effector T cells and
toward T
 
reg
 
 cells.
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